FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C.
20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of November 2009
Commission File Number: 000-51440
CHINA MEDICAL
TECHNOLOGIES, INC.
(Translation of registrants name into English)
No. 24 Yong Chang North Road
Beijing
Economic-Technological Development Area
Beijing 100176
Peoples Republic of China
(Address of
principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F
X
Form
40-F
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Indicate by
check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
No
X
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
82-
N/A
CHINA MEDICAL TECHNOLOGIES, INC.
Form 6-K
TABLE OF CONTENTS
|
|
|
|
|
Page
|
Signature
|
|
3
|
Exhibit 10.1 - China Medical Technologies, Inc. 2009 Equity Incentive Plan
|
|
4
|
Exhibit 99.1 - Press Release
|
|
13
|
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
CHINA MEDICAL TECHNOLOGIES, INC.
|
|
|
By:
|
|
/s/ Takyung (Sam) Tsang
|
Name:
|
|
Takyung (Sam) Tsang
|
Title:
|
|
Chief Financial Officer
|
Date: November 17, 2009
3
Exhibit 10.1
CHINA MEDICAL TECHNOLOGIES, INC.
2009 EQUITY
INCENTIVE PLAN
The
purpose of the Plan is to aid the Company and its Affiliates in recruiting and retaining key employees, directors or consultants of outstanding ability and to motivate such employees, directors or consultants to exert their best efforts on behalf of
the Company and its Affiliates by providing incentives through the granting of Awards. The Company expects that it will benefit from the added interest which such key employees, directors or consultants will have in the welfare of the Company as a
result of their proprietary interest in the Companys success.
The
following capitalized terms used in the Plan have the respective meanings set forth in this Section:
|
(a)
|
ADSs
: American Depositary Shares. Each ADS represents 10 Shares.
|
|
(b)
|
Applicable Laws
: All laws, statutes, regulations, ordinances, rules or governmental requirements that are applicable to this Plan or any Award granted pursuant
to this Plan, including but not limited to applicable laws of the Peoples Republic of China, the United States and the Cayman Islands, and the rules and requirements of any applicable national securities exchange.
|
|
(c)
|
Act
: The U.S. Securities Exchange Act of 1934, as amended, or any successor thereto.
|
|
(d)
|
Affiliate
: With respect to the Company, any entity directly or indirectly controlling, controlled by, or under common control with, the Company or any other
entity designated by the Board in which the Company or an Affiliate has an interest.
|
|
(e)
|
Award
: An Option, Stock Appreciation Right or Other Stock-Based Award granted pursuant to the Plan.
|
|
(f)
|
Beneficial Owner
: A beneficial owner, as such term is defined in Rule 13d-3 under the Act (or any successor rule thereto).
|
|
(g)
|
Board
: The Board of Directors of the Company.
|
|
(h)
|
Change in Control
: The occurrence of any of the following events:
|
|
(i)
|
the sale or disposition, in one or a series of related transactions, of all or substantially all, of the assets of the Company to any person or
group (as such terms are defined in Sections 13(d)(3) or 14(d)(2) of the Act) other than the Permitted Holders;
|
|
(ii)
|
any person or group, other than the Permitted Holders, is or becomes the Beneficial Owner (except that a person shall be deemed to have beneficial ownership
of all shares that any such person has the right to acquire, whether such right is exercisable immediately or only after the passage of time), directly or indirectly, of more than 50% of the total voting power of the voting stock of the Company (or
any entity which controls the Company), including by way of merger, consolidation, tender or exchange offer or otherwise; or
|
4
|
(iii)
|
during any period of two consecutive years, individuals who at the beginning of such period constituted the Board (together with any new directors whose election by
such Board or whose nomination for election by the shareholders of the Company was approved by a vote of a majority of the directors of the Company, then still in office, who were either directors at the beginning of such period or whose election or
nomination for election was previously so approved) cease for any reason to constitute a majority of the Board, then in office.
|
|
(i)
|
Code
: The U.S. Internal Revenue Code of 1986, as amended, or any successor thereto.
|
|
(j)
|
Committee
: The Compensation Committee of the Board.
|
|
(k)
|
Company
: China Medical Technologies, Inc., an exempted company incorporated under the laws of the Cayman Islands.
|
|
(l)
|
Disability
: Inability of a Participant to perform in all material respects his duties and responsibilities to the Company, or any Subsidiary of the Company, by
reason of a physical or mental disability or infirmity which inability is reasonably expected to be permanent and has continued (i) for a period of not less than 90 consecutive days or (ii) such shorter period as the Committee may
reasonably determine in good faith. The Disability determination shall be in the sole discretion of the Committee and a Participant (or his representative) shall furnish the Committee with medical evidence documenting the Participants
disability or infirmity which is satisfactory to the Committee.
|
|
(m)
|
Effective Date
: The date the Plan is approved by a meeting of the shareholders of the Company.
|
|
(n)
|
Employment
: The term Employment as used herein shall be deemed to refer to (i) a Participants employment if the Participant is an employee
of the Company or any of its Affiliates, (ii) a Participants services as a consultant, if the Participant is consultant to the Company or its Affiliates and (iii) a Participants services as an non-employee director, if the
Participant is a non-employee member of the Board.
|
|
(o)
|
Fair Market Value
: On a given date, the closing price of the ADSs as reported on the NASDAQ.
|
|
(p)
|
ISO
: An Option that is also an incentive stock option granted pursuant to Section 6(d) of the Plan.
|
|
(q)
|
LSAR
: A limited stock appreciation right granted pursuant to Section 7(d) of the Plan.
|
|
(r)
|
Other Stock-Based Awards
: Awards granted pursuant to Section 8 of the Plan.
|
|
(s)
|
Option
: A stock option granted pursuant to Section 6 of the Plan.
|
|
(t)
|
Option Price
: The purchase price per Share of an Option, as determined pursuant to Section 6(a) of the Plan.
|
|
(u)
|
Participant
: An employee, director or consultant who is selected by the Committee to participate in the Plan.
|
|
(v)
|
Permitted Holder
: means, as of the date of determination, (i) the Company or (ii) any employee benefit plan (or trust forming a part thereof)
maintained by (A) the Company or (B) any corporation or other Person of which a majority of its voting power of its voting equity securities or equity interest is owned, directly or indirectly, by the Company,
|
5
|
(w)
|
Person
: A person, as such term is used for purposes of Section 13(d) or 14(d) of the Act (or any successor section thereto).
|
|
(x)
|
Plan
: This China Medical Technologies, Inc. 2009 Equity Incentive Plan.
|
|
(y)
|
Shares
: Ordinary Shares of the Company, par value US$0.10 per share.
|
|
(z)
|
Stock Appreciation Right
: A stock appreciation right granted pursuant to Section 7 of the Plan.
|
|
(aa)
|
Subsidiary
: A corporation or other entity of which a majority of the outstanding voting shares or voting power is beneficially owned directly or indirectly by
the Company.
|
3.
|
Shares Subject to the Plan
|
The total number of Shares which may be issued under the Plan is 20,000,000, equivalent to 2,000,000 ADSs. The Shares may consist, in whole or in part, of authorized and unissued Shares, or Shares purchased on the open market. The issuance
of Shares or the payment of cash upon the exercise of an Award or in consideration of the cancellation or termination of an Award shall reduce the total number of Shares available under the Plan, as applicable. Shares which are subject to Awards
which terminate or lapse without the payment of consideration may be granted again under the Plan.
The Plan
shall be administered by the Committee, which may delegate its duties and powers in whole or in part to any subcommittee thereof consisting solely of the Chief Executive Officer and the Chief Financial Officer of the Company with respect to granting
Award to any Participant of the Plan who is not a director or officer of the Company. Awards may, in the discretion of the Committee, be made under the Plan in assumption of, or in substitution for, outstanding awards previously granted by the
Company or its Affiliates or a company acquired by the Company or with which the Company combines. The number of Shares underlying such substitute awards shall be counted against the aggregate number of Shares available for Awards under the Plan.
The Committee is authorized to interpret the Plan, to establish, amend and rescind any rules and regulations relating to the Plan, and to make any other determinations that it deems necessary or desirable for the administration of the Plan. The
Committee may correct any defect or supply any omission or reconcile any inconsistency in the Plan in the manner and to the extent the Committee deems necessary or desirable. Any decision of the Committee in the interpretation and administration of
the Plan, as described herein, shall lie within its sole and absolute discretion and shall be final, conclusive and binding on all parties concerned (including, but not limited to, Participants and their beneficiaries or successors). The Committee
shall have the full power and authority to establish the terms and conditions of any Award consistent with the provisions of the Plan and to waive any such terms and conditions at any time (including, without limitation, accelerating or waiving any
vesting conditions). The Committee shall require payment of any amount it may determine to be necessary to withhold for any applicable taxes as a result of the exercise, grant or vesting of an Award. Unless the Committee specifies otherwise, the
Participant may elect to pay a portion or all of such withholding taxes by (a) delivery in Shares or (b) having Shares withheld by the Company from any Shares that would have otherwise been received by the Participant.
No Award may
be granted under the Plan after the fifth anniversary of the Effective Date, but Awards granted may extend beyond that date.
6
6.
|
Terms and Conditions of Options
|
Options granted under the Plan shall be, as determined by the Committee, non-qualified or incentive stock options for U.S. federal income tax purposes, as evidenced by the related Award agreements, and shall be subject to the foregoing and
the following terms and conditions and to such other terms and conditions, not inconsistent therewith, as the Committee shall determine:
|
(a)
|
Option Price
. The Option Price per Share shall be determined by the Committee, but shall not be less than 100% of the Fair Market Value of the Shares on the date
an Option is granted.
|
|
(b)
|
Exercisability
. Options granted under the Plan shall be exercisable at such time and upon such terms and conditions as may be determined by the Committee, but in
no event shall an Option be exercisable more than five years after the date it is granted.
|
|
(c)
|
Exercise of Options
. Except as otherwise provided in the Plan or in an Award agreement, an Option may be exercised for all, or from time to time any part, of the
Shares for which it is then exercisable. For purposes of Section 6 of the Plan, the exercise date of an Option shall be the later of the date a notice of exercise is received by the Company and, if applicable, the date payment is received by
the Company pursuant to clauses (i), (ii), (iii) or (iv) in the following sentence. The purchase price for the Shares as to which an Option is exercised shall be paid to the Company in full at the time of exercise at the election of the
Participant (i) in cash or its equivalent (e.g., by check), (ii) to the extent permitted by the Committee, in Shares having a Fair Market Value equal to the aggregate Option Price for the Shares being purchased and satisfying such
other requirements as may be imposed by the Committee; provided, that such Shares have been held by the Participant for no less than six months (or such other period as established from time to time by the Committee in order to avoid adverse
accounting treatment applying generally accepted accounting principles), (iii) partly in cash and, to the extent permitted by the Committee, partly in such Shares or (iv) if there is a public market for the Shares at such time,
through the delivery of irrevocable instructions to a broker to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an amount out of the proceeds of such Sale equal to the aggregate Option Price for the Shares
being purchased. No Participant shall have any rights to dividends or other rights of a stockholder with respect to Shares subject to an Option until the Participant has given written notice of exercise of the Option, paid in full for such Shares
and, if applicable, has satisfied any other conditions imposed by the Committee pursuant to the Plan.
|
|
(d)
|
ISOs
. The Committee may grant Options under the Plan that are intended to be ISOs. Such ISOs shall comply with the requirements of Section 422 of the Code
(or any successor section thereto). No ISO may be granted to any Participant who at the time of such grant, owns more than ten percent of the total combined voting power of all classes of stock of the Company or of any Subsidiary, unless
(i) the Option Price for such ISO is at least 110% of the Fair Market Value of a Share on the date the ISO is granted and (ii) the date on which such ISO terminates is a date not later than the day preceding the fifth anniversary of the
date on which the ISO is granted. Any Participant who disposes of Shares acquired upon the exercise of an ISO either (i) within two years after the date of grant of such ISO or (ii) within one year after the transfer of such Shares to the
Participant, shall notify the Company of such disposition and of the amount realized upon such disposition. All Options granted under the Plan are intended to be nonqualified stock options, unless the applicable Award agreement expressly states that
the Option is intended to be an ISO. If an Option is intended to be an ISO, and if for any reason such Option (or portion thereof) shall not qualify as an ISO, then, to the extent of such nonqualification, such Option (or portion thereof) shall be
regarded as a nonqualified stock option granted under the Plan;
provided
that such Option (or portion thereof) otherwise complies with the Plans requirements relating to nonqualified stock options. In no event shall any member of the
Committee, the Company or any of its Affiliates (or their respective employees, officers or directors) have any liability to any Participant (or any other Person) due to the failure of an Option to qualify for any reason as an ISO.
|
7
|
(e)
|
Attestation
. Wherever in this Plan or any agreement evidencing an Award a Participant is permitted to pay the exercise price of an Option or taxes relating to
the exercise of an Option by delivering Shares, the Participant may, subject to procedures satisfactory to the Committee, satisfy such delivery requirement by presenting proof of beneficial ownership of such Shares, in which case the Company shall
treat the Option as exercised without further payment and shall withhold such number of Shares from the Shares acquired by the exercise of the Option.
|
7.
|
Terms and Conditions of Stock Appreciation Rights
|
|
(a)
|
Grants
. The Committee also may grant (i) a Stock Appreciation Right independent of an Option or (ii) a Stock Appreciation Right in connection with an
Option, or a portion thereof. A Stock Appreciation Right granted pursuant to clause (ii) of the preceding sentence (A) may be granted at the time the related Option is granted or at any time prior to the exercise or cancellation of the
related Option, (B) shall cover the same number of Shares covered by an Option (or such lesser number of Shares as the Committee may determine) and (C) shall be subject to the same terms and conditions as such Option except for such
additional limitations as are contemplated by this Section 7 (or such additional limitations as may be included in an Award agreement).
|
|
(b)
|
Terms
. The exercise price per Share of a Stock Appreciation Right shall be an amount determined by the Committee but in no event shall such amount be less than
the greater of (i) the Fair Market Value of a Share on the date the Stock Appreciation Right is granted or, in the case of a Stock Appreciation Right granted in conjunction with an Option, or a portion thereof, the Option Price of the related
Option and (ii) the minimum amount permitted by Applicable Laws. Each Stock Appreciation Right granted independent of an Option shall entitle a Participant upon exercise to an amount equal to (i) the excess of (A) the Fair Market
Value on the exercise date of one Share over (B) the exercise price per Share, times (ii) the number of Shares covered by the Stock Appreciation Right. Each Stock Appreciation Right granted in conjunction with an Option, or a portion
thereof, shall entitle a Participant to surrender to the Company the unexercised Option, or any portion thereof, and to receive from the Company in exchange therefore an amount equal to (i) the excess of (A) the Fair Market Value on the
exercise date of one Share over (B) the Option Price per Share, times (ii) the number of Shares covered by the Option, or portion thereof, which is surrendered. The date a notice of exercise is received by the Company shall be the exercise
date. Payment shall be made in Shares or in cash, or partly in Shares and partly in cash (any such Shares valued at such Fair Market Value), all as shall be determined by the Committee. Stock Appreciation Rights may be exercised from time to time
upon actual receipt by the Company of written notice of exercise stating the number of Shares with respect to which the Stock Appreciation Right is being exercised. No fractional Shares will be issued in payment for Stock Appreciation Rights, but
instead cash will be paid for a fraction or, if the Committee should so determine, the number of Shares will be rounded downward to the next whole Share.
|
|
(c)
|
Limitations
. The Committee may impose, in its discretion, such conditions upon the exercisability or transferability of Stock Appreciation Rights as it may deem
fit.
|
|
(d)
|
Limited Stock Appreciation Rights
. The Committee may grant LSARs that are exercisable upon the occurrence of specified contingent events. Such LSARs may provide
for a different method of determining appreciation, may specify that payment will be made only in cash and may provide that any related Awards are not exercisable while such LSARs are exercisable. Unless the context otherwise requires, whenever the
term Stock Appreciation Right is used in the Plan, such term shall include LSARs.
|
8
8.
|
Other Stock-Based Awards
|
The Committee, in its sole discretion, may grant or sell Awards of Shares, Awards of restricted Shares and Awards that are valued in whole or in part by reference to, or are otherwise based on the Fair Market Value of, Shares (Other
Stock-Based Awards). Such Other Stock-Based Awards shall be in such form, and dependent on such conditions, as the Committee shall determine, including, without limitation, the right to receive, or vest with respect to, one or more Shares (or
the equivalent cash value of such Shares) upon the completion of a specified period of service, the occurrence of an event and/or the attainment of performance objectives. Other Stock-Based Awards may be granted alone or in addition to any other
Awards granted under the Plan. Subject to the provisions of the Plan, the Committee shall determine to whom and when Other Stock-Based Awards will be made, the number of Shares to be awarded under (or otherwise related to) such Other Stock-Based
Awards; whether such Other Stock-Based Awards shall be settled in cash, Shares or a combination of cash and Shares; and all other terms and conditions of such Awards (including, without limitation, the vesting provisions thereof and provisions
ensuring that all Shares so awarded and issued shall be fully paid and non-assessable).
9.
|
Adjustments Upon Certain Events
|
Notwithstanding any other provisions in the Plan to the contrary, the following provisions shall apply to all Awards granted under the Plan:
|
(a)
|
Generally
. In the event of any change in the outstanding Shares after the Effective Date by reason of any Share dividend or split, reorganization,
recapitalization, merger, consolidation, spin-off, combination, combination or transaction or exchange of Shares or other corporate exchange, or any distribution to shareholders of Shares other than regular cash dividends or any transaction similar
to the foregoing, the Committee in its sole discretion and without liability to any person shall make such substitution or adjustment, if any, as it deems to be equitable, as to (i) the number or kind of Shares or other securities issued or
reserved for issuance pursuant to the Plan or pursuant to outstanding Awards, (ii) the maximum number of Shares for which Options or Stock Appreciation Rights may be granted during a calendar year to any Participant, (iii) the maximum
number of Shares for which Other Stock-Based Awards may be granted during a calendar year to any Participant, (iv) the maximum amount of an Award that is valued in whole or in part by reference to, or is otherwise based on the Fair Market Value
of, Shares that may be granted during a calendar year to any Participant, (v) the Option Price or exercise price of any stock appreciation right and/or (vi) any other affected terms of such Awards.
|
|
(b)
|
Change in Control
. In the event of a Change of Control after the Effective Date, (i) if determined by the Committee in the applicable Award
agreement or otherwise, any outstanding Awards then held by Participants which are unexercisable or otherwise unvested or subject to lapse restrictions shall automatically be deemed exercisable or otherwise vested or no longer subject to lapse
restrictions, as the case may be, as of immediately prior to such Change of Control and (ii) the Committee may, but shall not be obligated to, (A) cancel such Awards for fair value (as determined in the sole discretion of the Committee)
which, in the case of Options and Stock Appreciation Rights, may equal the excess, if any, of value of the consideration to be paid in the Change of Control transaction to holders of the same number of Shares subject to such Options or Stock
Appreciation Rights (or, if no consideration is paid in any such transaction, the Fair Market Value of the Shares subject to such Options or Stock Appreciation Rights) over the aggregate exercise price of such Options or Stock Appreciation Rights or
(B) provide for the issuance of substitute Awards that will substantially preserve the otherwise
|
9
|
applicable terms of any affected Awards previously granted hereunder as determined by the Committee in its sole discretion or (C) provide that for a period of at least 15 days prior to the
Change of Control, such Options shall be exercisable as to all Shares subject thereto and that upon the occurrence of the Change of Control, such Options shall terminate and be of no further force and effect.
|
10.
|
No Right to Employment or Awards
|
The granting of an Award under the Plan shall impose no obligation on the Company or any Subsidiary to continue the Employment of a Participant and shall not lessen or affect the Companys or Subsidiarys right to terminate the
Employment of such Participant. No Participant or other Person shall have any claim to be granted any Award, and there is no obligation for uniformity of treatment of Participants, or holders or beneficiaries of Awards. The terms and conditions of
Awards and the Committees determinations and interpretations with respect thereto need not be the same with respect to each Participant (whether or not such Participants are similarly situated).
11.
|
Successors and Assigns
|
The Plan shall be binding on all successors and assigns of the Company and a Participant, including without limitation, the estate of such Participant and the executor, administrator or trustee of such estate, or any receiver or trustee in
bankruptcy or representative of the Participants creditors.
12.
|
Nontransferability of Awards
|
Unless otherwise determined by the Committee, an Award shall not be transferable or assignable by the Participant otherwise than by will or by the laws of descent and distribution. An Award exercisable after the death of a Participant may
be exercised by the legatees, personal representatives or distributees of the Participant.
Notwithstanding the foregoing, no
provision herein shall prevent or forbid transfers by will, by the laws of descent and distribution, to a trust that was established solely for tax planning purposes and not for purposes of profit or commercial activity or, to one or more
family members (as such term is defined in SEC Rule 701 promulgated under the Securities Act of 1933, as amended) by gift or pursuant to a qualified domestic relations order.
13.
|
Amendments or Termination
|
The Board may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation shall be made, (a) without the approval of the shareholders of the Company, if such action would (except as is provided in
Section 9 of the Plan), increase the total number of Shares reserved for the purposes of the Plan or change the maximum number of Shares for which Awards may be granted to any Participant or (b) without the consent of a Participant, if
such action would diminish any of the rights of the Participant under any Award granted to such Participant under the Plan; provided, however, that the Committee may amend the Plan in such manner as it deems necessary to permit the granting of
Awards meeting the requirements of any Applicable Laws.
Without limiting the generality of the foregoing, to the extent
applicable, notwithstanding anything herein to the contrary, this Plan and Awards issued hereunder shall be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other interpretative guidance issued
thereunder, including without limitation any such regulations or other guidance that may be issued after the Effective Date. Notwithstanding any provision of the Plan to the contrary, in the event that the Committee determines that any amounts
payable hereunder will be taxable to a Participant under Section 409A of the Code and related Department of Treasury guidance prior to payment to such Participant of such amount, the Company may
10
(a) adopt such amendments to the Plan and Awards and appropriate policies and procedures, including amendments and policies with retroactive effect, that the Committee determines necessary
or appropriate to preserve the intended tax treatment of the benefits provided by the Plan and Awards hereunder and/or (b) take such other actions as the Committee determines necessary or appropriate to comply with the requirements of
Section 409A of the Code.
In order
to assure the viability of Awards granted to Participants employed in various jurisdictions, the Committee may, in its sole discretion, may provide for such special terms as it may consider necessary or appropriate to accommodate differences in
local law, tax policy or custom applicable in the jurisdiction in which the Participant resides or is employed. Moreover, the Committee may approve such supplements to, amendments, restatements, or alternative versions of the Plan as it may consider
necessary or appropriate for such purposes without thereby affecting the terms of the Plan as in effect for any other purpose; provided, however, that no such supplements, restatements or alternative versions shall increase the Share limitation
contained in Section 3 hereof. Notwithstanding the foregoing, the Committee may not take any actions hereunder, and no Awards shall be granted that would violate any Applicable Laws.
15.
|
Distribution of Shares
|
The obligation of the Company to make payments in Shares pursuant to an Award shall be subject to all Applicable Laws and to any such approvals by government agencies as may be required. Without limiting the generality of the foregoing,
Shares distributed pursuant to an Award may consist, in whole or in part, of authorized and unissued Shares, or Shares purchased on the open market. Additionally, in the discretion of the Committee, American Depository Shares may be distributed in
lieu of Shares in settlement of any Award, provided that the American Depository Shares shall be of equal value to the Shares that would have otherwise been distributed. If the number of Shares represented by an American Depository Share is other
than on a one-to-one basis, the limitations of Section 3 shall be adjusted to reflect the distribution of American Depository Shares in lieu of Shares.
No Shares shall be
delivered under the Plan to any Participant until such Participant has made arrangements acceptable to the Committee for the satisfaction of any income and employment tax withholding obligations under any Applicable Laws, in particular, the tax
laws, rules, regulations and government orders of the Peoples Republic of China or the U.S. federal, state or other local tax laws, as applicable. The Company and each of its Subsidiaries shall have the authority and the right to deduct or
withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy federal, state, local and foreign taxes (including the Participants payroll tax obligations, if any) required to be withheld under any Applicable Laws
with respect to any Award issued to the Participant hereunder. The Committee may in its discretion and in satisfaction of the foregoing requirement allow a Participant to elect to have the Company withhold Shares otherwise issuable under an Award
(or allow the return of Shares) having a Fair Market Value equal to the sums required to be withheld. Notwithstanding any other provision of the Plan, the number of Shares which may be withheld with respect to the issuance, vesting, exercise or
payment of any Award (or which may be repurchased form the Participant of such Award after such Shares were acquired by the Participant from the Company) in order to satisfy the Participants federal, state, local and other income and payroll
tax liabilities with respect to the issuance, vesting, exercise or payment of the Award shall, unless specifically approved by the Committee, be limited to the number of Shares which have a Fair Market Value on the date of withholding or repurchase
equal to the aggregate amount of such liabilities based on the minimum statutory withholding rates for federal, state, local and other income tax any payroll tax purposes that are applicable to such taxable income.
11
The Plan
shall be governed by and construed in accordance with the laws of the state of New York.
18.
|
Effectiveness of the Plan
|
The Plan shall be effective as of the Effective Date and shall terminate five years later, subject to earlier termination by the Board pursuant to Section 13 hereof.
12
Exhibit 99.1
China Medical Technologies Announces Shareholder Resolution Adopted at its Annual
General Meeting Held on November 16, 2009
Beijing, November 17, 2009 China Medical Technologies, Inc. (the Company) (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets
advanced in-vitro diagnostic products, today announced shareholder resolution adopted at its annual general meeting of shareholders held in Beijing on November 16, 2009.
At the annual general meeting, the Companys shareholders approved the China Medical Technologies, Inc. 2009 Equity Incentive Plan (the 2009 Plan) as adopted by the Companys board
of directors and proposed for shareholders approval by the Company. The terms of the 2009 Plan can be found in the Companys Form 6-K furnished to the U.S. Securities and Exchange Commission (the SEC) on November 17,
2009, which can be accessed on the Companys Investor Relations website at http://ir.chinameditech.com and on the SECs website at http://www.sec.gov. The Companys shareholders did not adopt any other resolution at the annual general
meeting.
About China Medical Technologies, Inc.
China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA)
technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please visit http://www.chinameditech.com.
Contact
Winnie Yam
Tel: 852-2511-9808
Email:
IR@chinameditech.com
13
China Medical (NASDAQ:CMED)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Medical (NASDAQ:CMED)
Historical Stock Chart
From Jul 2023 to Jul 2024